The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma.
The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma.
复制标题
EBV 和感染胃组织从前驱病变到癌的基因组结构
DOI:
10.1186/s13073-021-00963-2
复制
发表时间:
2021-09-07
期刊:
影响因子:
12.3
通讯作者:
Zhong Q
中科院分区:
文献类型:
--
作者:
Chen ZH;Yan SM;Chen XX;Zhang Q;Liu SX;Liu Y;Luo YL;Zhang C;Xu M;Zhao YF;Huang LY;Liu BL;Xia TL;Xu DZ;Liang Y;Chen YM;Wang W;Yuan SQ;Zhang HZ;Yun JP;Zhai WW;Zeng MS;Bai F;Zhong Q
BackgroundEpstein-Barr virus (EBV)-associated gastric carcinomas (EBVaGCs) present unique molecular signatures, but the tumorigenesis of EBVaGCs and the role EBV plays during this process remain poorly understood.MethodsWe applied whole-exome sequencing, EBV genome sequencing, and whole-genome bisulfite sequencing to multiple samples (n= 123) derived from the same patients (n= 25), which covered saliva samples and different histological stages from morphologically normal epithelial tissues to dysplasia and EBVaGCs. We compared the genomic landscape between EBVaGCs and their precursor lesions and traced the clonal evolution for each patient. We also analyzed genome sequences of EBV from samples of different histological types. Finally, the key molecular events promoting the tumor evolution were demonstrated by MTT, IC50, and colony formation assayin vitroexperiments andin vivoxenograft experiments.ResultsOur analysis revealed increasing mutational burden and EBV load from normal tissues and low-grade dysplasia (LD) to high-grade dysplasia (HD) and EBVaGCs, and oncogenic amplifications occurred late in EBVaGCs. Interestingly, within each patient, EBVaGCs and HDs were monoclonal and harbored single-strain-originated EBV, but saliva or normal tissues/LDs had different EBV strains from that in EBVaGCs. Compared with precursor lesions, tumor cells showed incremental methylation in promotor regions, whereas EBV presented consistent hypermethylation. Dominant alterations targeting the PI3K-Akt and Wnt pathways were found in EBV-infected cells. The combinational inhibition of these two pathways in EBV-positive tumor cells confirmed their synergistic function.ConclusionsWe portrayed the (epi) genomic evolution process of EBVaGCs, revealed the extensive genomic diversity of EBV between tumors and normal tissue sites, and demonstrated the synergistic activation of the PI3K and Wnt pathways in EBVaGCs, offering a new potential treatment strategy for this disease.
登录
查看更多内容
影响因子:
5.4
作者:
Midgley, RS;Bell, AI;Rickinson, AB
通讯作者:
Rickinson, AB
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
影响因子:
16.6
作者:
Chen XX;Zhong Q;Liu Y;Yan SM;Chen ZH;Jin SZ;Xia TL;Li RY;Zhou AJ;Su Z;Huang YH;Huang QT;Huang LY;Zhang X;Zhao YN;Yun JP;Wu QL;Lin DX;Bai F;Zeng MS
通讯作者:
Zeng MS
影响因子:
50.3
作者:
Mazor T;Pankov A;Johnson BE;Hong C;Hamilton EG;Bell RJA;Smirnov IV;Reis GF;Phillips JJ;Barnes MJ;Idbaih A;Alentorn A;Kloezeman JJ;Lamfers MLM;Bollen AW;Taylor BS;Molinaro AM;Olshen AB;Chang SM;Song JS;Costello JF
通讯作者:
Costello JF
影响因子:
5.8
作者:
Akalin, Altuna;Franke, Vedran;Schuebeler, Dirk
通讯作者:
Schuebeler, Dirk